VERTEX PHARMACEUTICALS INC / MA (VRTX) › Total AssetsVERTEX PHARMACEUTICALS INC / MA (VRTX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2009: $1.96B2010: $1.73B2011: $2.20B2012: $2.76B2013: $2.32B2014: $2.33B2015: $2.50B2016: $2.90B2017: $3.55B2018: $6.25B2019: $8.32B2020: $11.75B2021: $13.43B2022: $18.15B2023: $22.73B2024: $22.53B2025: $25.64B$25.64B2009Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$25.64B+13.8%2024$22.53B-0.9%2023$22.73B+25.2%2022$18.15B+35.1%2021$13.43B+14.3%2020$11.75B+41.3%2019$8.32B+33.2%2018$6.25B+76.1%2017$3.55B+22.4%2016$2.90B+15.9%2015$2.50B+7.0%2014$2.33B+0.7%2013$2.32B-16.0%2012$2.76B+25.2%2011$2.20B+27.8%2010$1.73B-11.8%2009$1.96B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share